{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:34:10Z","timestamp":1792056850302,"version":"4.4.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>To provide new insights into pathogenesis, prevention and management of cardiac manifestations of neonatal lupus (cardiac neonatal lupus) and issues pertinent to all anti-SSA\/Ro positive individuals of childbearing age.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Antibody specificity with high risk for cardiac neonatal lupus remains elusive, but high titers of Ro60, Ro52 or Ro52p200 antibodies appear to be required. Varying antibody specificities to the p200 region of Ro52 can induce first-degree block in a rodent model. In consideration of the contribution of macrophages to inflammation and fibrosis in cardiac neonatal lupus, hydroxychloroquine (HCQ) is being considered as preventive therapy. Cord blood biomarkers support the association of fetal reactive inflammatory and fibrotic components with the development and morbidity of cardiac neonatal lupus. Data from U.S. and French registries do not provide evidence that the prompt use of fluorinated steroids in cases of isolated block significantly alters fetal\/neonatal morbidity or mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The search for a high-risk cardiac neonatal lupus antibody profile remains, but high-titer antibodies to Ro60 and R052 are a consistent finding, and this may guide the need for fetal echocardiographic surveillance. The uniform use of fluorinated steroids to prevent progression of cardiac neonatal lupus or reduce mortality does not appear justified. HCQ, based on diminishing an inflammatory component of cardiac neonatal lupus, is under consideration as a potential preventive approach.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000414","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T14:25:06Z","timestamp":1495031106000},"page":"467-472","source":"Crossref","is-referenced-by-count":51,"title":["Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus"],"prefix":"10.1097","volume":"29","author":[{"given":"Peter","family":"Izmirly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Buyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198307283090403","article-title":"Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block","volume":"309","author":"Scott","year":"1983","journal-title":"N Engl J Med"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-4939-0673-4_13","article-title":"Neonatal lupus","author":"Mendez","year":"2014","journal-title":"Contraception and Pregnancy in Patients with Rheumatic Disease"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/aogs.12785","article-title":"Outcome in 212\u200aanti-Ro\/SSA-positive pregnancies and population-based incidence of congenital heart block","volume":"95","author":"Skog","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/art.24768","article-title":"Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal\/fetal risk factors","volume":"60","author":"Llanos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multiracial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"key":"R7-20230829","first-page":"2413","article-title":"Impaired clearance of apoptotic cardiocytes is linked to anti-SSA\/Ro and -SSB\/La antibodies in the pathogenesis of congenital heart block","volume":"116","author":"Clancy","year":"2006","journal-title":"J Clin Invest"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/0961203307085115","article-title":"Dying right to live longer: positing apoptosis as a link between maternal autoantibodies and congenital heart block","volume":"17","author":"Buyon","year":"2008","journal-title":"Lupus"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.4049\/jimmunol.0902248","article-title":"Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block","volume":"184","author":"Clancy","year":"2010","journal-title":"J Immunol"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.RES.80.3.354","article-title":"Arrhythmogenicity of IgG and anti52-kD SSA\/Ro affinity-purified antibodies from mothers of children with congenital heart block","volume":"80","author":"Boutjdir","year":"1997","journal-title":"Circ Res"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1203\/00006450-199807000-00002","article-title":"Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model","volume":"44","author":"Boutjdir","year":"1998","journal-title":"Pediatr Res"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaut.2009.06.005","article-title":"Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) L-type Ca channel","volume":"34","author":"Karnabi","year":"2010","journal-title":"J Autoimmun"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/art.23377","article-title":"A B cell apotope of Ro 60 in systemic lupus erythematosus","volume":"58","author":"Reed","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.1780340613","article-title":"Sera from patients with autoimmune disease recognize conformational determinants on the 60-kd Ro\/SS-A protein","volume":"34","author":"Boire","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/art.10232","article-title":"A serologic marker for fetal risk of congenital heart block","volume":"46","author":"Salomonsson","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2249.2008.03732.x","article-title":"Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block","volume":"154","author":"Strandberg","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1002\/art.21289","article-title":"Maternal antibody responses to the 52-kd SSA\/RO p200 peptide and the development of fetal conduction defects","volume":"52","author":"Clancy","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/acr.21704","article-title":"Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus","volume":"64","author":"Reed","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"e000129","DOI":"10.1136\/lupus-2015-000129","article-title":"Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients","volume":"3","author":"Tonello","year":"2016","journal-title":"Lupus Sci Med"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"e000154","DOI":"10.1136\/lupus-2016-000154","article-title":"In search of an antibody specificity highly predictive of congenital heart block","volume":"3","author":"Izmirly","year":"2016","journal-title":"Lupus Sci Med"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/cei.12854","article-title":"Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model","volume":"186","author":"Hoxha","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.4049\/jimmunol.1001396","article-title":"Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block","volume":"185","author":"Strandberg","year":"2010","journal-title":"J Immunol"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/rheumatology\/ker515","article-title":"Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus","volume":"51","author":"Llanos","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jaut.2015.09.003","article-title":"Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7\/8 ligation to forestall tissue injury in anti-Ro60 associated heart block","volume":"67","author":"Clancy","year":"2016","journal-title":"J Autoimmun"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine","volume":"69","author":"Izmirly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jacc.2015.06.1088","article-title":"Serum biomarkers of inflammation, fibrosis, and cardiac function in facilitating diagnosis, prognosis, and treatment of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"66","author":"Saxena","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.111.041970","article-title":"Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients","volume":"124","author":"Eliasson","year":"2011","journal-title":"Circulation"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3","article-title":"Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus","volume":"42","author":"Saleeb","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/uog.1713","article-title":"Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature","volume":"24","author":"Breur","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am J Cardiol"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/ard.62.10.1010","article-title":"Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block","volume":"62","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R33-20230829","first-page":"144","article-title":"Antenatal corticosteroids revisited: repeat courses \u2013 National Institutes of Health Consensus Development Conference Statement, August 17\u201318, 2000","volume":"98","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","article-title":"Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease","volume":"110","author":"Jaeggi","year":"2004","journal-title":"Circulation"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/CIRCULATIONAHA.107.735118","article-title":"Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution","volume":"118","author":"Lopes","year":"2008","journal-title":"Circulation"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2015-208311","article-title":"Assessment of fluorinated steroids to avert progression and mortality in anti-SSA\/Ro-associated cardiac injury limited to the fetal conduction system","volume":"75","author":"Izmirly","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1542\/peds.106.1.86","article-title":"Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn","volume":"106","author":"Eronen","year":"2000","journal-title":"Pediatrics"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0735-1097(01)01697-7","article-title":"Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years","volume":"39","author":"Jaeggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/14397595.2015.1106661","article-title":"Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies","volume":"26","author":"Tsuboi","year":"2016","journal-title":"Mod Rheumatol"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.autrev.2015.08.005","article-title":"Description of 214 cases of autoimmune congenital heart block: results of the French neonatal lupus syndrome","volume":"14","author":"Levesque","year":"2015","journal-title":"Autoimmun Rev"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201709000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T06:47:15Z","timestamp":1693291635000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201709000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000414","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}